Showing results (331-340 of 1,300) with videos related to

Sort By:
Pageof 130
JACC. Case Reports|March 28, 2025
Treatment of Mitral and Tricuspid Atrioventricular Valve Disease by Double Transcatheter Valve ReplacementCyril David Ferro, Caroline Chong-Nguyen, Daryoush Samim, et al.
European Heart Journal|February 11, 2014
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantationSigmund Silber, Ajay J Kirtane, Jorge A Belardi, et al.
ESC Heart Failure|October 19, 2022
SGLT2 inhibitor therapy for transthyretin amyloid cardiomyopathy: early tolerance and clinical response to dapagliflozinStephan Dobner, Benedikt Bernhard, Babken Asatryan, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 14, 2022
Impact of First-Phase Ejection Fraction on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve ImplantationDaijiro Tomii, Taishi Okuno, Caglayan Demirel, et al.
JACC. Cardiovascular Interventions|July 11, 2020
Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart DiseaseFaisal Khan, Taishi Okuno, Daniel Malebranche, et al.
JACC. Cardiovascular Interventions|November 27, 2024
Conduction Disturbances After Transcatheter Aortic Valve Replacement: An Update on Epidemiology, Preventive Strategies, and ManagementJorge Nuche, Kenneth A Ellenbogen, Suneet Mittal, et al.
International Journal of Cardiology|December 24, 2005
The 2002 European registry of cardiac catheter interventionsWillibald Maier, Michael Abay, Stéphane Cook, et al.
Echocardiography (Mount Kisco, N.Y.)|December 19, 2002
Validation of six noninvasive Doppler methods for the assessment of left ventricular filling pressureNils Kucher, Markus Schwerzmann, Ernst Lipp, et al.
Lancet (London, England)|November 15, 2011
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialGiulio G Stefanini, Bindu Kalesan, Patrick W Serruys, et al.
Lancet (London, England)|September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialStephan Windecker, Patrick W Serruys, Simon Wandel, et al.
Pageof 130